Evidence map›Paper›PMID 29593706›Full record

ArticleFrontiers in immunology2018

Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a

Hongwei Wang, Yibo Zhang, Xiaojin Wu, Yufeng Wang, Hanwei Cui, Xinxin Li, Jianying Zhang, Norman Tun, Yong Peng, Jianhua Yu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Molecular Mechanism of TRAF6 in Malignant Proliferation of Human NK/T Cell Lymphoma Cell HANK1.Mediterranean journal of hematology and infectious diseases · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Recent Advances of RNA mCancer treatment and research · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hongwei WangThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Yibo ZhangThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Xiaojin WuThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Yufeng WangThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Hanwei CuiThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Xinxin LiThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Jianying ZhangDepartment of Bioinformatics, The Ohio State University, Columbus, OH, United States.
Norman TunThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Yong PengState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Jianhua YuThe Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
The Ohio State University · USFirst Affiliated Hospital of Soochow University · CNState Key Laboratory of Biotherapy

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Elucidate and Modulate Cell Signaling in NK Cells for Glioma TreatmentR01AI129582 · NIAID · OHIO STATE UNIVERSITY · PI YU, JIANHUA · 2017 to 2021
$2.1M
Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-CadherinR01NS106170 · NINDS · OHIO STATE UNIVERSITY · PI YU, JIANHUA · 2018 to 2023
$1.9M
NCI NIH HHS P30 CA016058NIAID NIH HHS R01 AI129582NINDS NIH HHS R01 NS106170
6 · The paper itself

Abstract

Natural killer (NK) cells are one group of innate lymphocytes that are important for host defense against malignancy and viruses. MicroRNAs (miRNAs) play a critical role in regulating responses of immune cells including NK cells. Accumulating evidence suggests that miR-146a is involved in the regulation of immune responses. However, the mechanism by which miR-146a regulates NK cell function is largely unknown. In the current study, we found that miR-146a intrinsically regulated NK cell function. Forced overexpression of miR-146a decreased IFN-γ production, whereas downregulation of miR-146a by anti-miR-146a significantly enhanced IFN-γ production in the human NK-92 cell line and primary human NK cells upon stimulation with IL-12 or co-stimulation with IL-12 and IL-18. Mechanistically, miR-146a regulated IFN-γ production

Indexed as

Cells, CulturedHumansInterferon-gammaKiller Cells, NaturalMicroRNAsNF-kappa BSignal TransductionInterferon-gammaMicroRNAsMIRN146 microRNA, humanNF-kappa BIFN-γIRAK1microRNAmiR-146anatural killer cellsNF-κBTRAF6

Identifiers

PMID29593706
PMCPMC5854688
OpenAlexW2790757707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.